- Informed consent from participants with decisional capacity or their legally authorized |
- Potential risks, benefits and uncertainties |
representative should be obtained |
- Relevant information about the trial, should also be presented visually |
- Composition of the product |
- Patients should be encouraged to ask questions |
- The irreversible nature of the intervention |
- Scientific jargon should be avoided by using only simple words or easily understood terminology |
- How adverse events will be dealt with - The right and practical difficulty |
- The teach-back method, exams or questionnaires could be used to ensure that participants |
to withdraw |
understand the relevant information |
- How life-long follow up will be organized |
- Participants should be encouraged to ask independent experts/patient advocates for advice or assistance in the decision-making process |
- The possibility to consent for partial or complete autopsy in the event of death |
- Participants need to be informed that the intervention is not likely to provide direct medical benefits |